Page last updated: 2024-12-05

4-methylbenzophenone

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

4-Methylbenzophenone is a colorless solid with a melting point of 52-54 °C and a boiling point of 315-316 °C. It is soluble in organic solvents such as ethanol and diethyl ether. The compound is commonly synthesized through Friedel-Crafts acylation of toluene with benzoyl chloride in the presence of a Lewis acid catalyst, such as aluminum chloride. 4-Methylbenzophenone is a useful intermediate in the synthesis of various organic compounds and is employed in the production of polymers, pharmaceuticals, and dyes. This compound is also explored for its potential applications in organic electronics, optoelectronics, and photocatalysis due to its unique electronic and optical properties. The compound is typically studied for its structure-property relationships, its role as a photocatalyst, and its potential as a building block for advanced materials. Its photocatalytic activity stems from its ability to absorb ultraviolet light and generate reactive oxygen species that can be used to degrade pollutants.'

4-methylbenzophenone: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID8652
CHEMBL ID371531
SCHEMBL ID235
MeSH IDM0546277

Synonyms (58)

Synonym
EN300-20231
p-benzoyltoluene
wln: 1r dvr
nsc-4898
nsc4898
4-methylbenzophenone
134-84-9
phenyl p-tolyl ketone
methanone, (4-methylphenyl)phenyl-
p-methylbenzophenone
benzophenone, 4-methyl-
usaf do-54
nsc 4898
ai3-18452
4-methyl benzophenone
p-benzophenone, methyl-
einecs 205-159-1
4-methylbenzophenone, 99%
NCGC00164221-01
(4-methyphenyl)(phenyl)methanone
AC-11601
(4-methylphenyl)-phenylmethanone
AKOS003809024
(4-methylphenyl)(phenyl)methanone
CHEMBL371531
4-methybenzophenone
4-methylbenzophenone-d3
M1248
4-methyl-benzophenone
dtxsid9037741 ,
tox21_301629
cas-134-84-9
NCGC00255430-01
dtxcid7017741
42343-24-8
FT-0671519
phenyl(p-tolyl)methanone
b2f68x17bm ,
unii-b2f68x17bm
FT-0619064
AM20060847
4-methylphenyl phenyl ketone
AE-641/00364041
SCHEMBL235
4-benzoyltoluene
phenyl-p-tolyl-methanone
(4-methylphenyl)phenylmethanone
W-108279
STR09876
PS-8267
mfcd00008553
4-methylbenzophenone, analytical standard
benzyl methyl sulfide, united states pharmacopeia (usp) reference standard
SY009656
CS-W010591
AC7898
Q27274279
Z104477368
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (11)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
LuciferasePhotinus pyralis (common eastern firefly)Potency31.70550.007215.758889.3584AID1224835
AR proteinHomo sapiens (human)Potency65.72080.000221.22318,912.5098AID1259243; AID1259247
nuclear receptor subfamily 1, group I, member 3Homo sapiens (human)Potency37.13730.001022.650876.6163AID1224838; AID1224839; AID1224893
retinoic acid nuclear receptor alpha variant 1Homo sapiens (human)Potency34.62740.003041.611522,387.1992AID1159552; AID1159553; AID1159555
pregnane X nuclear receptorHomo sapiens (human)Potency31.62280.005428.02631,258.9301AID720659
estrogen nuclear receptor alphaHomo sapiens (human)Potency21.68990.000229.305416,493.5996AID743079
vitamin D (1,25- dihydroxyvitamin D3) receptorHomo sapiens (human)Potency11.22020.023723.228263.5986AID588543
thyroid stimulating hormone receptorHomo sapiens (human)Potency21.68990.001628.015177.1139AID1224843
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_aHomo sapiens (human)Potency61.644819.739145.978464.9432AID1159509
histone deacetylase 9 isoform 3Homo sapiens (human)Potency37.80400.037617.082361.1927AID1259364; AID1259388
nuclear factor erythroid 2-related factor 2 isoform 1Homo sapiens (human)Potency1.53550.000627.21521,122.0200AID720636
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID257050Inhibition of recombinant human AKR1C3 at 50 uM2005Bioorganic & medicinal chemistry letters, Dec-01, Volume: 15, Issue:23
Nonsteroidal anti-inflammatory drugs and their analogues as inhibitors of aldo-keto reductase AKR1C3: new lead compounds for the development of anticancer agents.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (13)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (7.69)29.6817
2010's12 (92.31)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 37.97

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index37.97 (24.57)
Research Supply Index2.64 (2.92)
Research Growth Index4.97 (4.65)
Search Engine Demand Index47.49 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (37.97)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other13 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]